Sections
Shortcuts
Business

Harvard Bioscience stock

Harvard Bioscience develops tools for life-sciences research and regenerative medicine.
Harvard Bioscience develops tools for life-sciences research and regenerative medicine.Essdras M Suarez/Globe Staff/File 2011

This is a summary. To read the whole story subscribe to BostonGlobe.com

Harvard Bioscience Inc.’s board of directors this week elected Jeffrey A. Duchemin as chief executive of the Holliston company. The interim CEO, David Green, will continue as president until the spin-off of the regenerative medicine subsidiary, which Green will head. Most recently, Duchemin was global business director for Corning Life Sciences

Full story for BostonGlobe.com subscribers.

Get the full story with unlimited access to BostonGlobe.com.

Just 99 cents for four weeks.

Sections
Shortcuts

Share